Abstract:Drug resistance remains one of the main causes of poor outcome in cancer therapy. It is also becoming evident that drug resistance to both chemotherapy and to antibiotics is driven by more than one mechanism. So far, there are at least eight recognized mechanisms behind such resistance. In this review, we choose to discuss one of these mechanisms, which is known to be partially driven by a class of transmembrane proteins known as ATP-binding cassette (ABC) transporters. In normal tissues, ABC transporters protect the cells from the toxic effects of xenobiotics, whereas in tumor cells, they reduce the intracellular concentrations of anticancer drugs, which ultimately leads to the emergence of multidrug resistance (MDR). A deeper understanding of the structures and the biology of these proteins is central to current efforts to circumvent resistance to both chemotherapy, targeted therapy, and antibiotics. Understanding the biology and the function of these proteins requires detailed structural and conformational information for this class of membrane proteins. For many years, such structural information has been mainly provided by X-ray crystallography and cryo-electron microscopy. More recently, mass spectrometry-based methods assumed an important role in the area of structural and conformational characterization of this class of proteins. The contribution of this technique to structural biology has been enhanced by its combination with liquid chromatography and ion mobility, as well as more refined labelling protocols and the use of more efficient fragmentation methods, which allow the detection and localization of labile post-translational modifications. In this review, we discuss the contribution of mass spectrometry to efforts to characterize some members of the ATP-binding cassette (ABC) proteins and why such a contribution is relevant to efforts to clarify the link between the overexpression of these proteins and the most widespread mechanism of chemoresistance.

ATP-Binding Cassette and Solute Carrier Transporters: Understanding Their Mechanisms and Drug Modulation Through Structural and Modeling Approaches

The Important Role of Transporter Structures in Drug Disposition, Efficacy, and Toxicity.

Atomistic Molecular Dynamics Simulations of ATP‐binding Cassette Transporters

Structural View of Cryo-Electron Microscopy-Determined ATP-Binding Cassette Transporters in Human Multidrug Resistance

Plastic Structures for Diverse Substrates: A Revisit of Human ABC Transporters

ABC transporters: human disease and pharmacotherapeutic potential

Computational Models for Predicting Interactions with Membrane Transporters

Post-translational modifications of transporters

Computational Chemistry in Structure-Based Solute Carrier Transporter Drug Design: Recent Advances and Future Perspectives

The impact of ATP-binding cassette transporters on metabolic diseases

Understanding of Human ATP Binding Cassette Superfamily and Novel Multidrug Resistance Modulators to Overcome MDR

Mass Spectrometry Investigation of Some ATP-Binding Cassette (ABC) Proteins

Oligomerization of human ATP-binding cassette transporters and its potential significance in human disease

ABC Transporter and Its Application in Synthetic Biology

Potential Application of Network Descriptions for Understanding Conformational Changes and Protonation States of ABC Transporters

Microscopic Characterization of Membrane Transporter Function by In Silico Modeling and Simulation

Mechanistic diversity in ATP-binding cassette (ABC) transporters

Future opportunities in solute carrier structural biology

Structural and Functional Diversity Calls for a New Classification of ABC Transporters

The impact of ATP-binding cassette transporters in the diseased brain: Context matters

Jump into a New Fold—A Homology Based Model for the ABCG2/BCRP Multidrug Transporter